{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:25:15Z","timestamp":1793053515525,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Subclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Of the 605 subjects consecutively referred for monolateral adrenal incidentalomas (AIs) to our outpatient clinics, 55 SH patients (recruited on the basis of the exclusion criteria) were enrolled. We suggested to all patients to undergo adrenalectomy, which was accepted by 32 patients (surgical group, age 61.3\u00b18.1 years) and refused by 23 patients, who were followed with a conservative management (non-surgical group, age 65.4\u00b17.1 years).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We diagnosed SH in patients with serum cortisol after 1\u200amg dexamethasone suppression test (1\u200amg-DST) &gt;5.0\u200a\u03bcg\/dl or with greater than or equal to two criteria among 1\u200amg-DST &gt;3.0\u200a\u03bcg\/dl, urinary free cortisol &gt;70\u200a\u03bcg\/24\u200ah and ACTH &lt;10\u200apg\/ml. We assessed: bone mineral density (BMD) at lumbar spine (LS) and femoral neck (as<jats:italic>Z<\/jats:italic>-score) by dual-energy X-ray absorptiometry and the VFx presence by X-ray at baseline and at the end of follow up (surgical group 39.9\u00b120.9 months and non-surgical group 27.7\u00b111.1 months).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The LS<jats:italic>Z<\/jats:italic>-score (\u0394<jats:italic>Z<\/jats:italic>-score\/year) tended to increase in the surgical group (0.10\u00b10.20) compared with the non-surgical group (\u22120.01\u00b10.27,<jats:italic>P<\/jats:italic>=0.08) and in the former, the percentage of patients with new VFx was lower (9.4%) than in the latter (52.2%,<jats:italic>P<\/jats:italic>&lt;0.0001). Surgery in AI patients with SH was associated with a 30% VFx risk reduction (odds ratio 0.7, 95% CI 0.01\u20130.05,<jats:italic>P<\/jats:italic>=0.008) regardless of age, gender, follow up duration, 1\u200amg-DST, LS BMD, and presence of VFx at baseline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients with monolateral AI and SH, adrenalectomy reduces the risk of VFx.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-15-0977","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T01:52:55Z","timestamp":1449107575000},"page":"261-269","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":70,"title":["Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism"],"prefix":"10.1093","volume":"174","author":[{"given":"Antonio Stefano","family":"Salcuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Eller Vainicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2016011518231073000_174.3.261.1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0889-8529(05)70115-8","article-title":"Subclinical Cushing's syndrome","volume":"29","author":"Reincke","year":"2000","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"2016011518231073000_174.3.261.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2722"},{"key":"2016011518231073000_174.3.261.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.2.637"},{"key":"2016011518231073000_174.3.261.4","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344099"},{"key":"2016011518231073000_174.3.261.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.998"},{"key":"2016011518231073000_174.3.261.6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12020-012-9628-9","article-title":"Glucose metabolism in patients with subclinical Cushing's syndrome","volume":"41","author":"Giordano","year":"2012","journal-title":"Endocrine"},{"key":"2016011518231073000_174.3.261.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1440"},{"key":"2016011518231073000_174.3.261.8","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1039"},{"key":"2016011518231073000_174.3.261.9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016011518231073000_174.3.261.10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet. Diabetes & Endocrinology"},{"key":"2016011518231073000_174.3.261.11","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016011518231073000_174.3.261.12","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31819a47d2"},{"key":"2016011518231073000_174.3.261.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2387"},{"key":"2016011518231073000_174.3.261.14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0707"},{"key":"2016011518231073000_174.3.261.15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF03345601","article-title":"Skeletal involvement in adults patients with endogenous hypercortisolism","volume":"31","author":"Chiodini","year":"2008","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016011518231073000_174.3.261.16","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450241"},{"key":"2016011518231073000_174.3.261.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.7.2381"},{"key":"2016011518231073000_174.3.261.18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020399"},{"key":"2016011518231073000_174.3.261.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0468"},{"key":"2016011518231073000_174.3.261.20","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.398"},{"key":"2016011518231073000_174.3.261.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.05.007"},{"key":"2016011518231073000_174.3.261.22","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2007.S5"},{"key":"2016011518231073000_174.3.261.23"},{"key":"2016011518231073000_174.3.261.24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.rcl.2010.02.018","article-title":"Vertebral morphometry","volume":"48","author":"Diacinti","year":"2010","journal-title":"Radiologic Clinics of North America"},{"key":"2016011518231073000_174.3.261.25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4081\/reumatismo.2011.129","article-title":"Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)","volume":"63","author":"Adami","year":"2011","journal-title":"Reumatismo"},{"key":"2016011518231073000_174.3.261.26","first-page":"260","article-title":"Guidelines for the diagnosis, prevention and treatment of osteoporosis. Societ\u00e0 Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro","volume":"61","author":"Adami","year":"2009","journal-title":"Reumatismo"},{"key":"2016011518231073000_174.3.261.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0543-5"},{"key":"2016011518231073000_174.3.261.28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00198-013-2588-y","article-title":"Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?","volume":"25","author":"Scillitani","year":"2014","journal-title":"Osteoporosis International"},{"key":"2016011518231073000_174.3.261.29","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460051"},{"key":"2016011518231073000_174.3.261.30","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1648"},{"issue":"Suppl 7","key":"2016011518231073000_174.3.261.31","first-page":"33","article-title":"Densitometry in glucocorticoid-induced osteoporosis","volume":"31","author":"Chiodini","year":"2008","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016011518231073000_174.3.261.32","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1147"},{"key":"2016011518231073000_174.3.261.33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.beem.2012.02.001","article-title":"Subclinical Cushing's syndrome","volume":"26","author":"De Leo","year":"2012","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"2016011518231073000_174.3.261.34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01676.x"},{"key":"2016011518231073000_174.3.261.35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2010.03794.x","article-title":"Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects","volume":"73","author":"Morelli","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"2016011518231073000_174.3.261.36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0602"},{"key":"2016011518231073000_174.3.261.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.3.320"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/3\/261.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/3\/261.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T17:02:43Z","timestamp":1748710963000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/174\/3\/261\/6655503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":37,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0977","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}